Singularity Future Technology Ltd. - Common Stock, no par value (SGLY)

CUSIP: 82935V307

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, no par value
Shares outstanding
4,166,679
Total 13F shares
677
Share change
+677
Total reported value
$3,453
Price per share
$5.10
Number of holders
4
Value change
+$3,453
Number of buys
4

Quarterly Holders Quick Answers

What is CUSIP 82935V307?
CUSIP 82935V307 identifies SGLY - Singularity Future Technology Ltd. - Common Stock, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SGLY - Singularity Future Technology Ltd. - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
TWO SIGMA INVESTMENTS, LP
13F
Company
class O/S missing
72,873
$39,351 31 Dec 2023
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
class O/S missing
25,100
$13,554 31 Dec 2023
13F
HighTower Advisors, LLC
13F
Company
class O/S missing
16,000
$9,000 31 Dec 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
class O/S missing
13,510
$7,295 31 Dec 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
11,251
$6,075 31 Dec 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
1,664
$899 31 Dec 2023
13F
Qube Research & Technologies Ltd
13F
Company
class O/S missing
96
$52 31 Dec 2023
13F
Lei Cao
3/4/5
Chief Executive Officer, Director
class O/S missing
1,021,008
13 Aug 2021
Yang Jie
3/4/5
Chief Executive Officer, Director
class O/S missing
300,000
09 Feb 2022
Lei Nie
3/4/5
Vice President
class O/S missing
279,000
13 Aug 2021
Tuo Pan
3/4/5
Chief Financial Officer
class O/S missing
279,000
13 Aug 2021
Zhi Kang Huang
3/4/5
Director
class O/S missing
248,000
13 Aug 2021
Jing Wang
3/4/5
Former independent director
class O/S missing
146,000
15 Dec 2021
Jing Shan
3/4/5
Chief Operating Officer
class O/S missing
100,000
09 Feb 2022
Shi Qiu
3/4/5
Chief Technology Officer
class O/S missing
100,000
09 Feb 2022
Tieliang Liu
3/4/5
Director
mixed-class rows
50,000
mixed-class rows
13 Aug 2021
Xiaohuan Huang
3/4/5
Director
class O/S missing
20,000
13 Aug 2021

Institutional Holders of Singularity Future Technology Ltd. - Common Stock, no par value (SGLY) as of Q1 2024

As of 31 Mar 2024, Singularity Future Technology Ltd. - Common Stock, no par value (SGLY) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 677 shares. The largest 4 holders included UBS Group AG, BANK OF AMERICA CORP /DE/, Qube Research & Technologies Ltd, and Creekmur Asset Management LLC. This page lists 4 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2024 vs Q4 2025 Across Filers

Q4 2025 holders
9
Q1 2024 holders
4
Holder diff
-5
Investor Q4 2025 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .